Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into a strategic partnership with Serve Accurate Faithful Evaluation (SAFE), a contract research organization (CRO) co-founded by the Chinese Academy of Sciences (CAS) in 2016, Suzhou Institute of Materia Medica, Clinical Service Center, and SPD BANK. This collaboration aims to leverage their combined strengths across industry, academia, and finance to expedite the advancement of pharmaceutical research and development.
The partnership seeks to enhance cooperation in upgrading the pharmaceutical R&D industry, bolster regional brand development, and other related areas. Together, they aim to establish a comprehensive, one-stop innovative drug service platform that provides end-to-end solutions. The financial details of this agreement were not disclosed.- Flcube.com
